Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-09-04 00:00:00 ET · period of report 2025-09-02 · accession 0001230724-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-04 | 2025-09-02 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $31.56 | -5,080 | 131.0K | -4% | -$160.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-02 | F | D | 1,429 | $31.56 | 127,199 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 2 | Common | Common Stock | 2025-09-02 | F | D | 2,381 | $31.56 | 128,628 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
| 3 | Common | Common Stock | 2025-09-02 | F | D | 1,270 | $31.56 | 131,009 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. (F2) Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025. |